Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression-Reference-Cited by-同舟云学术

Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression

Published:2003-12 Issue:1-2 Volume:147 Page:149-155
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Kuo Dong-Yih

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference34 articles.

1. DA1 receptor activity opposes anorectic responses to amino acid-imbalanced diets;Aja;Pharmacol. Biochem. Behav.,1999

2. Evidence for the involvement of dopamine D1 and D2 receptors in mediating the decrease of food intake during repeated treatment with amphetamine;Chen;J. Biomed. Sci.,2001

3. Cooper SJ, Al-Naser HA. D1:D2 dopamine receptor interactions in relation to feeding responses and food intake. In: Waddington J, editor. D1:D2 dopamine receptor interactions. San Diego: Academic Press; 1993. p. 203–34.

4. Effects of d- and l-amphetamine on food intake: evidence for a dopaminergic substrate;Evans;Pharmacol. Biochem. Behav.,1987

5. Effects of amphetamine on food and fruit drink self-administration;Foltin;Exp. Clin. Psychopharmacol.,2000

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La activación sistémica de los receptores a dopamina D2-like disminuye la ingesta de alimento en ratas;Revista Mexicana de Trastornos Alimentarios;2024-09-05

2. Environmentally relevant levels of four psychoactive compounds vary in their effects on freshwater fish condition: a brain concentration evidence approach;PeerJ;2020-07-09

3. Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor Overactivation in Striatal Neurons;Frontiers in Neuroscience;2020-06-23

4. CNS-targeting pharmacological interventions for the metabolic syndrome;Journal of Clinical Investigation;2019-08-05

5. A Critical Review of Repurposing Apomorphine for Smoking Cessation;ASSAY and Drug Development Technologies;2015-12